Does the human immune system ever really become "senescent"?

F1000Research

Volumn 6, Issue , 2017, Pages

  Pawelec, Graham ^a,b,c,d  

^a HEALTH SCIENCES NORTH   (Canada)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Immune aging; Immune cell distribution; Immune system; Immunoscenecene; Inflammaging

Indexed keywords

ADAPTIVE IMMUNITY; AGING; AUTOIMMUNITY; CARDIOVASCULAR DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; HUMAN; IMMUNE SYSTEM; IMMUNOSENESCENCE; INFECTION; INNATE IMMUNITY; MALIGNANT NEOPLASM; MORTALITY; OUTCOME ASSESSMENT; REVIEW; RISK FACTOR; VACCINATION;

EID: 85027287193     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.11297.1     Document Type: Review

References (41)

1. Stahl EC Brown BN: Cell Therapy Strategies to Combat Immunosenescence. Organogenesis. 2015;11(4):159-72. 26588595 10.1080/15476278.2015.1120046 4879890
2. Faragher R Frasca D Remarque E: Better immunity in later life: a position paper. Age (Dordr). 2014;36(3):9619. 24532368 10.1007/s11357-014-9619-2 4082593
3. Capri M Monti D Salvioli S: Complexity of anti-immunosenescence strategies in humans. Artif Organs. 2006;30(10):730-42. 17026572 10.1111/j.1525-1594.2006.00295.x
4. Hayflick L: Human cells and aging. Sci Am. 1968;218(3):32-7. 5636319
5. Harley CB Futcher AB Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345(6274):458-60. 2342578 10.1038/345458a0
6. Izaks GJ Remarque EJ Becker SV: Lymphocyte count and mortality risk in older persons. The Leiden 85-Plus Study. J Am Geriatr Soc. 2003;51(10):1461-5. 14511169 10.1046/j.1532-5415.2003.51467.x
7. Fagnoni FF Vescovini R Passeri G: Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. Blood. 2000;95(1):2860-8. 10779432
8. Derhovanessian E Maier AB Beck R: Hallmark features of immunosenescence are absent in familial longevity. J Immunol. 2010;185(8):4618-24. 20855876 10.4049/jimmunol.1001629 F1000 Recommendation
9. Wertheimer AM Bennett MS Park B: Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans. J Immunol. 2014;192(5):2143-55. 24501199 10.4049/jimmunol.1301721 3989163 F1000 Recommendation
10. Derhovanessian E Maier AB Hähnel K: Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4+ and CD8+ T-cells in humans. J Gen Virol. 2011;92(Pt 12):2746-56. 21813708 10.1099/vir.0.036004-0
11. Weltevrede M Eilers R de Melker HE: Cytomegalovirus persistence and T-cell immunosenescence in people aged fifty and older: A systematic review. Exp Gerontol. 2016;77:87-95. 26883338 10.1016/j.exger.2016.02.005 F1000 Recommendation
12. Hecker M Qiu D Marquardt K: Continuous cytomegalovirus seroconversion in a large group of healthy blood donors. Vox Sang. 2004;86(1):41-4. 14984558 10.1111/j.0042-9007.2004.00388.x
13. Dowd JB Aiello AE Alley DE: Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III. Epidemiol Infect. 2009;137(1):58-65. 18413004 10.1017/S0950268808000551 3806637
14. Alam I Goldeck D Larbi A: Aging affects the proportions of T and B cells in a group of elderly men in a developing country--a pilot study from Pakistan. Age (Dordr). 2013;35(5):1521-30. 22810104 10.1007/s11357-012-9455-1 3776124
15. Di Benedetto S Derhovanessian E Steinhagen-Thiessen E: Impact of age, sex and CMV-infection on peripheral T cell phenotypes: results from the Berlin BASE-II Study. Biogerontology. 2015;16(5):631-43. 25732234 10.1007/s10522-015-9563-2
16. Stervbo U Bozzetti C Baron U: Effects of aging on human leukocytes (part II): immunophenotyping of adaptive immune B and T cell subsets. Age (Dordr). 2015;37(5):93. 26324156 10.1007/s11357-015-9829-2 5005833 F1000 Recommendation
17. Stervbo U Meier S Mälzer JN: Effects of aging on human leukocytes (part I): immunophenotyping of innate immune cells. Age (Dordr). 2015;37(5):92. 26324155 10.1007/s11357-015-9828-3 5005831 F1000 Recommendation
18. Thome JJ Farber DL: Emerging concepts in tissue-resident T cells: lessons from humans. Trends Immunol. 2015;36(7):428-35. 26072286 10.1016/j.it.2015.05.003 4491028
19. Schulz AR Mälzer JN Domingo C: Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195(10):4699-711. 26459351 10.4049/jimmunol.1500598 F1000 Recommendation
20. Aspinall R Andrew D: Thymic involution in aging. J Clin Immunol. 2000;20(4):250-6. 10939712 10.1023/A:1006611518223
21. Shanley DP Aw D Manley NR: An evolutionary perspective on the mechanisms of immunosenescence. Trends Immunol. 2009;30(7):374-81. 19541538 10.1016/j.it.2009.05.001
22. Fuertes Marraco SA Soneson C Cagnon L: Long-lasting stem cell-like memory CD8 + T cells with a naïve-like profile upon yellow fever vaccination. Sci Transl Med. 2015;7(282):282ra48. 25855494 10.1126/scitranslmed.aaa3700 F1000 Recommendation
23. Donnelly CA Ghani AC Leung GM: Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet. 2003;361(9371):1761-6. 12781533 10.1016/S0140-6736(03)13410-1
24. Mosterín Höpping A McElhaney J Fonville JM: The confounded effects of age and exposure history in response to influenza vaccination. Vaccine. 2016;34(4):540-6. 26667611 10.1016/j.vaccine.2015.11.058 4724805 F1000 Recommendation
25. Derhovanessian E Maier AB Hähnel K: Latent infection with cytomegalovirus is associated with poor memory CD4 responses to influenza A core proteins in the elderly. J Immunol. 2014;193(7):3624-31. 25187662 10.4049/jimmunol.1303361
26. McElhaney JE Kuchel GA Zhou X: T-Cell Immunity to Influenza in Older Adults: A Pathophysiological Framework for Development of More Effective Vaccines. Front Immunol. 2016;7:41. 26941738 10.3389/fimmu.2016.00041 4766518
27. Hsu HT Mace EM Carisey AF: NK cells converge lytic granules to promote cytotoxicity and prevent bystander killing. J Cell Biol. 2016;215(6):875-89. 27903610 10.1083/jcb.201604136 5166499 F1000 Recommendation
28. Voskoboinik I Whisstock JC Trapani JA: Perforin and granzymes: function, dysfunction and human pathology. Nat Rev Immunol. 2015;15(6):388-400. 25998963 10.1038/nri3839
29. McElhaney JE Zhou X Talbot HK: The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine. 2012;30(12):2060-7. 22289511 10.1016/j.vaccine.2012.01.015 3345132
30. Michaud M Balardy L Moulis G: Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc. 2013;14(12):877-82. 23792036 10.1016/j.jamda.2013.05.009
31. Franceschi C Bonafè M Valensin S: Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244-54. 10911963 10.1111/j.1749-6632.2000.tb06651.x
32. Tchkonia T Zhu Y van Deursen J: Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest. 2013;123(3):966-72. 23454759 10.1172/JCI64098 3582125
33. Wikby A Ferguson F Forsey R: An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J Gerontol A Biol Sci Med Sci. 2005;60(5):556-65. 15972602 10.1093/gerona/60.5.556
34. Ferrando-Martínez S Romero-Sánchez MC Solana R: Thymic function failure and C-reactive protein levels are independent predictors of all-cause mortality in healthy elderly humans. Age (Dordr). 2013;35(1):251-9. 22095260 10.1007/s11357-011-9341-2 3543745
35. Pawelec G Ferguson FG Wikby A: The SENIEUR protocol after 16 years. Mech Ageing Dev. 2001;122(2):132-4. 11166351 10.1016/S0047-6374(00)00240-2
36. Solana R Tarazona R Gayoso I: Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Semin Immunol. 2012;24(5):331-41. 22560929 10.1016/j.smim.2012.04.008
37. Barron E Lara J White M: Blood-borne biomarkers of mortality risk: systematic review of cohort studies. PLoS One. 2015;10(6):e0127550. 26039142 10.1371/journal.pone.0127550 4454670 F1000 Recommendation
38. Belsky DW Caspi A Houts R: Quantification of biological aging in young adults. Proc Natl Acad Sci U S A. 2015;112(30):E4104-10. 26150497 10.1073/pnas.1506264112 4522793 F1000 Recommendation
39. Adriaensen W Pawelec G Vaes B: CD4:8 Ratio Above 5 Is Associated With All-Cause Mortality in CMV-Seronegative Very Old Women: Results From the BELFRAIL Study. J Gerontol A Biol Sci Med Sci. 2016; pii: glw215. 27927759 10.1093/gerona/glw215
40. Denkinger MD Leins H Schirmbeck R: HSC Aging and Senescent Immune Remodeling. Trends Immunol. 2015;36(12):815-24. 26611154 10.1016/j.it.2015.10.008 4710174 F1000 Recommendation
41. Oh J Lee YD Wagers AJ: Stem cell aging: mechanisms, regulators and therapeutic opportunities. Nat Med. 2014;20(8):870-80. 25100532 10.1038/nm.3651 4160113